May 19, 2020

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States

“As the central Massachusetts biotech community continues its growth, WuXi Biologics’ arrival in Worcester will strengthen the sector and lead to ongoing economic development.”

WuXi Biologics (“WuXi Bio”), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in Worcester at The Reactory, a 46-acre master-planned biomanufacturing campus. The approximately 107,000-square-foot, two-story facility will be operational in 2022 and create 150 new jobs.